Report
US Treasury proposes investment curbs on parts of Chinese biotech
POLITICO reports a Treasury official declined to clarify whether or how proposed rules would cover co-development and co-marketing agreements.
TLDR
Treasury proposed curbs on investment in parts of Chinese biotech, AI and advanced chips Oct. 22, the Financial Times reports. POLITICO says a Treasury official told reporters the proposal does not address licensing deals but declined to clarify whether or how it would apply to co-development and co-marketing agreements. POLITICO also reports China separately proposed restricting foreign sales of some biopharma innovations; the Biotechnology Innovation Organization warns overly broad U.S. curbs could weaken competitiveness.
Combined views
50.9K
7 Sources, first seen ago
